4-BENZYL-2-(IODOMETHYL)-2,6,6-TRIMETHYLMORPHOLINE, 95.0%, 250mg

(1R,2S)-2-fluorocyclopropane-1-carbonitrile, 98%, 1g

BETRIXABAN, 95%, 250mg

Tert-butyl 4-((6-bromopyridin-3-yl)methyl)piperazine-1-carboxylate, 98%, 1g

4-(4-Hydroxyphenyl)-2-butanone>99.0%(GC)25g

Ethyl 3-bromoisonicotinate, 95.0%, 1g

2-Bromo-4-fluorobenzoyl chloride, 95.0%, 1g

2-Ethynyloxetane, 98%, 250mg

Z-Pro-ONp, 95.0%, 1g

3-Cyclopentyl-1H-pyrazol-5-amine, 95.0%, 500mg

2,1,3-benzothiadiazol-4-ol, 250mg

(2E)-3-[4-(Methylsulfonyl)phenyl]propenoic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-1701, 50 m, 0.53 mm, 2.00 µm, 1 Piece(s)